Results 141 to 150 of about 2,021 (171)

Editorial: Therapeutics in pulmonary arterial hypertension. [PDF]

Front Cardiovasc Med
Adão R, Perez-Vizcaino F, Redwan B, Brás-Silva C.   +3 more
europepmc   +1 more source

Engineering of Saccharomyces cerevisiae as a platform strain for microbial production of sphingosine-1-phosphate. [PDF]

Microb Cell Fact
Jang IS, Lee SJ, Bahn YS, Baek SH, Yu BJ.   +4 more
europepmc   +1 more source

Discovery and Characterization of VU0542270, the First Selective Inhibitor of Vascular Kir6.1/SUR2B K_ATP Channels. [PDF]

Mol Pharmacol
Li K, McClenahan SJ, Han C, Bungard JD, Rathnayake U, Boutaud O, Bauer JA, Days EL, Lindsley CW, Shelton EL, Denton JS.   +10 more
europepmc   +1 more source

Expression of SUR1 isoforms in the brain and heart after ischemia/reperfusion. [PDF]

Front Mol Neurosci
Alquisiras-Burgos I, Peralta-Arrieta I, Espinoza-Rojo M, Salazar-Salgado A, Antonino-Olguín I, Sánchez-Mendoza A, Sánchez-Aguilar M, Ruiz-Tachiquín ME, Valdez-Salazar HA, Ortiz-Plata A, Franco-Pérez J, Hernández-Cruz A, Aguilera P.   +12 more
europepmc   +1 more source

<i>Yarrowia lipolytica</i> as a promising cell factory for microbial production of value-added nutraceuticals. [PDF]

Front Bioeng Biotechnol
Lee S, Lee JH, Park HJ, Baek SH.
europepmc   +1 more source

Low-Dose Oral Minoxidil during Chemotherapy: A Review of the Mechanism and Current Evidence. [PDF]

Skin Appendage Disord
Kearney CA, Gordon A, Markova A, Freites-Martinez A, Tattersall IW, Shapiro J, Lacouture ME, Lo Sicco KI.   +7 more
europepmc   +1 more source

Barriers, Limitations, and Experiences with Clinical Trials-Treatment in Rare Diseases with Prader-Willi Syndrome as an Example. [PDF]

Genes (Basel)
Butler MG, Silvey S, van Bosse HJP.
europepmc   +1 more source

Unlocking hypoglycemia-associated brain microvascular dysfunction: critical insights from proteomic analysis. [PDF]

Neural Regen Res
Sakamuri SSVP, Sakamuri A.
europepmc   +1 more source

Intramolecular interaction of SUR2 subtypes for intracellular ADP-induced Differential control of KATP channels

Intramolecular interaction of SUR2 subtypes for intracellular ADP-induced Differential control of KATP channels
openaire   +1 more source

EXPRESSION AND PURIFICATION OF A SOLUBLE ESX-BINDING CORE DOMAIN OF SUR2

Preparative Biochemistry and Biotechnology, 2013
For HER2 overexpression, the ESX transcription factor must interact with both the HER2 promoter and Sur2, a subunit of human mediator complex, using its Ets domain and transactivation domain, respectively. HER2 overexpression is a marker of poor prognosis in various types of cancers. Thus, interfering with the ESX-Sur2 interaction has been suggested as
Youngjoo Kwon, Kyung-Hwa Jeon, Kyu-Yeon Jun   +2 more
exaly   +4 more sources